Diametric Capital, LP Atea Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

  • $173 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$2.8 - $3.35 $107,732 - $128,894
-38,476 Reduced 19.24%
161,524 $492,000
Q3 2023

Nov 14, 2023
BUY
$3.0 - $3.79 $375,000 - $473,750
125,000 Added 166.67%
200,000 $600,000
Q2 2023

Aug 11, 2023
BUY
$3.21 - $5.06 $240,750 - $379,499
75,000 New
75,000 $280,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $271M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email